Three types of phenotypic expression of ␤-lactam resistance have been reported in methicillin-resistant Staphylococcus aureus (MRSA): heterogeneous, homogeneous, and Eagle-type resistance. Heterogeneous-to-homogeneous conversion of ␤-lactam resistance is postulated to be caused by a chromosomal mutation (chr*) in addition to the expression of the mecA gene. Eagle-type resistance is a unique phenotype of chr* occurring in pre-MRSA strain N315 whose mecA gene expression is strongly repressed by an intact mecI gene. We here report that certain mutations of the rpoB gene, encoding the RNA polymerase ␤ subunit, belong to chr*. We studied homogeneous MRSA (homo-MRSA) strain N315⌬IP-H5 (abbreviated as ⌬IP-H5), which was obtained from hetero-MRSA strain N315⌬IP by selection with 8 mg/liter imipenem. Whole-genome sequencing of ⌬IP-H5 revealed the presence of a unique mutation in the rpoB gene, rpoB(N967I), causing the amino acid replacement of Asn by Ile at position 967 of RpoB. The effect of the rpoB(N967I) mutation was confirmed by constructing a revertant H5 rpoB(I967N) strain as well as an N315-derived mutant, N315 rpoB(N967I). H5 rpoB(I967N) regained the hetero-resistance phenotype, and the N315 rpoB(N967I) strain showed an Eagle-type phenotype similar to that of the typical Eagle-type MRSA strain N315h4. Furthermore, subsequent whole-genome sequencing revealed that N315h4 also had a missense mutation of rpoB(R644H). Introduction of the rpoB(N967I) mutation was accompanied by decreased autolysis, prolonged doubling time, and tolerance to bactericidal concentrations of methicillin. We consider that rpoB mutations are the major cause for heterogeneous-to-homogeneous phenotypic conversion of ␤-lactam resistance in MRSA strain N315 and its derived strains.
M
ethicillin resistance in staphylococcal species is mediated by production of penicillin-binding protein 2= (PBP2=) (or PBP2a), the ␤-lactam-insensitive cell wall synthesis enzyme encoded by the mecA gene (1) (2) (3) (4) (5) . Since most of the clinically used ␤-lactam antibiotics do not bind to PBP2= appreciably at therapeutic concentrations, they are ineffective in the treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA). However, the production of PBP2= alone dose not make the cells uniformly resistant to ␤-lactam. The expression of PBP2= makes the bacterial strain a mixture of cell subpopulations with different levels of ␤-lactam resistance. This peculiar resistance phenotype is known as heterogeneous methicillin resistance (hetero-type resistance). Exposure of the hetero-MRSA strain to ␤-lactam antibiotics selects out mutant strains whose entire cell populations are uniformly highly resistant to ␤-lactam antibiotics. The resistance phenotype is called homogeneous methicillin resistance (homo-type resistance). Ryffel et al. and Berger-Bachi and Rohrer postulated the occurrence of a spontaneous chromosomal mutation (chr*) that is responsible for heterogeneous-to-homogeneous conversion of methicillin resistance (6, 7) . The mutation chr* was considered unlinked to the mecA gene complex, which was acquired exogenously as a mobile genetic element (6) .
The third phenotype of ␤-lactam resistance, called Eagle type, is known for an unusual distribution of resistant cell subpopulations, as revealed by population analysis (8, 9) . Eagle-type MRSA grows better on agar plates containing high concentrations of methicillin than on those with low concentrations of methicillin (10) . The phenotype is observed only in the rare category of strains called pre-MRSA (11, 12) . Despite the presence of an intact mecA gene, pre-MRSA is methicillin susceptible (oxacillin MIC of Ͻ4 mg/liter) since PBP2= is not expressed due to the repressor function encoded by the mecI gene (11, 13) . Pre-MRSA N315 is a typical Japanese hospital-acquired MRSA strain belonging to staphylococcal cassette chromosome mec (SCCmec) type II (subtype 2A; ccr gene complex type 2 and mec complex class A) (14) (15) (16) and sequence type 5 (17) . Selection of N315 with low concentrations (10 mg/liter) of methicillin yields a hetero-MRSA strain (12) . On the other hand, selection of N315 with a high concentration (Ն128 mg/liter) of methicillin yields an Eagle-type strain (10) . Subsequent inactivation of the mecI gene converts the Eagletype MRSA to homo-MRSA strain (10) . The experiments indicated that the genetic event converts pre-MRSA to Eagle-type MRSA, which is equivalent to chr* mutation in homo-MRSA. The experiments also indicated that tolerance to high concentrations of methicillin is associated with chr* mutation. Therefore, derepressed expression of PBP2= and high-dose methicillin tolerance are the two requisites for homogeneous methicillin resistance (10) .
The search for chr* has been our long-term interest. So far, four genes, llm, lytH, hmrA, and hmrB, have been isolated for which either activation or inactivation causes heterogeneous-to-homogeneous phenotypic conversion (7, 10, 18, 19) . We previously reported that we cloned two genes, hmrA and hmrB, as the genes associated with the chr* phenotype. Overexpression of hmrA or hmrB converts hetero-MRSA to homo-MRSA and converts pre-MRSA to Eagle-type MRSA (10). Then we found the mutation vraS(S329L) in a transcription regulator that converted hetero-MRSA strain N315⌬IP into a homo-MRSA strain, with a concomitant rise in vancomycin resistance (20) . The mutation vraS (S329L) caused constitutive expression of cell wall synthesis that rationally increased resistance to cell wall inhibitor antibiotics. This was the gene that satisfied the criteria for chr* mutation. In this study, we report that mutation in rpoB encoding the ␤ subunit of RNA polymerase holoenzyme constitutes another category of chr*. We have previously proposed that rpoB mutation is a regulatory mutation that influences the susceptibility of the cell to vancomycin (21, 22) , daptomycin (23, 24) , and linezolid (22) . Here, we further extend our view that rpoB mutation can also influence ␤-lactam resistance, conferring both homogeneous methicillin resistance and Eagle-type methicillin resistance to S. aureus cells, depending on the mode of expression of the mecA gene.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. S. aureus and plasmids used in this study are listed in Table 1 . The cloning and transformation of Escherichia coli strain DH5␣ were carried out by standard techniques (TaKaRa-Bio Co., Ltd., Shiga, Japan). All S. aureus strains were grown in brain heart infusion (BHI) broth or agar (Becton, Dickinson and Co.
[BD], Franklin Lakes, NJ), with aeration at 37°C for over 18 h. The antibiotics ampicillin (Wako Pure Chemical Industries, Osaka, Japan), chloramphenicol (Sigma Chemical Co., St. Louis, MO), methicillin (SmithKline Beecham/GlaxoSmithKline, London, United Kingdom), and imipenem (WAKO) were used in this study.
DNA methods.
The standard methods of DNA manipulations were described previously (25) . Genomic DNAs and plasmid were prepared with Miniamp and Miniprep kits (Qiagen, Inc., Valencia, CA). Restriction enzymes were used as recommended by the manufacturer (TaKaRa). Routine PCR amplification was performed with an Expand High-Fidelity system (Roche, Mannheim, Germany).
Whole-genome sequencing of ⌬IP-H5 and SNP analysis compared to the sequence of parent strain N315⌬IP. Sequencing of the genome of strain N315⌬IP-H5 (abbreviated as ⌬IP-H5) was performed with a Genome Sequencer 20 system, a recently introduced highly parallel genome sequencer from 454 Life Sciences (Branford, CT). The sequence assembly and gap closing were carried out as described previously (20) . Since ⌬IP-H5 is an in vitro derivative of N315, the resulting sequence of the ⌬IP-H5 genome was then compared to that of N315, and then the discovery of genome-wide single nucleotide polymorphisms (SNPs) was achieved by whole-genome alignments with the Mummer (version 3.20) software package (http://mummer.sourceforge.net/). PCR amplification and sequencing of ⌬IP-H5 chromosomal DNA found no additional mutations except for an rpoB mutation, which causes the replacement of a single amino acid, Asn 967, with Ile (N967I).
SNP analysis. To analyze SNPs of three strains, H5 rpoB(I967N), N315 rpoB(N967I), and N315h4, 90-bp paired-end read sequencing was performed using a Hiseq2000 sequencing platform (Illumina Inc., San Diego, CA) at the infoBio company (Tokyo, Japan). Sequences of 90-bp paired-end reads from each bacterial strain were obtained in a single lane of a flow cell. Image analysis was performed with Illumina's Pipeline Analysis software, version 1.8. The 15.1-Mb, 18.2-Mb, and 15.9-Mb reads were obtained from the chromosomal DNA library of strains H5 rpoB(I967N), N315 rpoB(N967I), and N315h4, respectively. As de novo DNA analysis, each read was mapped to the reference whole-genome sequence of N315, and then mapping of SNPs was extracted by using the software Genome Traveler (in silico Biology Inc., Yokohama, Japan).
Construction of mutant strains N315 rpoB(N967I) and H5 rpoB(I967N). For the chromosomal allele replacement of rpoB(N967I) in N315 or rpoB(I967N) in ⌬IP-H5, we used the pKOR1 allele replacement system, as described previously (26) . In brief, a 3.0-kb of rpoB insert DNA encompassing a 1-kb flanking sequence of a phage attachment site was generated by PCR from chromosomal DNA of strain N315 or ⌬IP-H5 by using the following primers: attB1-rpoB (5=-GGGGACAAGTTTGTACA AAAAAAGCAGGCT-3=) and attB2-rpoB (5=-GGGGACCACTTTGTAC AAGAAAGCTGGGT-3=). The resulting plasmid, pKO-rpoB(967I) or pKO-rpoB(967N) was introduced into S. aureus N315 or ⌬IP-H5 by electroporation, generating transformant N315(pKO-rpoB
). The replacement of the rpoB gene was carried out by a two-step procedure. We identified the desired strains H5 rpoB(I967N) and N315 rpoB(N967I) by determination of the nucleotide sequence using the following three primers; 5=-CAGCTGGATGGCAAA TAATG-3=, 5=-TGTGGAATTGTGAGCGGATA-3=, and 5=-AATTGCGC TTTACCGCCAAGTGGTTGT-3=. Also we confirmed the absence of
FIG 1 Population analysis of N315 and its derivatives with exposure to imipenem (A) and methicillin (B)
. Pre-MRSA strain N315, hetero-type strain N315⌬IP, typical Eagle-type strain N315h4, and homo-type strain ⌬IP-H5 were used as control strains. Note that N315 rpoB(N967I) showed an Eagle-type phenotype similar to that of N315h4. other additional mutations in the mutants by SNP analysis, except for a mutation of sa0168(M199V) in N315 rpoB(N967I). Antibiotic susceptibility. The susceptibility of several antibiotics was examined by Etest (AB Biodisk, Solna, Sweden) and population analysis, as described previously (10) . All examinations were performed by using BHI broth or agar plates.
Transmission electron microscopy. The preparation and the examination of S. aureus cells by transmission electron microscopy were performed as described previously (22, 27) . At least 120 cells of each sample with nearly equatorial cut surfaces were measured for the evaluation of cell wall thickness, and the results were expressed as the means Ϯ standard deviations.
Doubling time. The doubling time was calculated, as described previously (22) . The growth conditions were 37°C with shaking at 25 rpm in a TN-2612 incubator (Advantec, Osaka, Japan). The optical density at 660 nm (OD 660 ) versus time was plotted for each strain in the exponential growth phase. A linear regression curve was obtained from values between the log 2 OD 660 and the log 2 t, where t is time (R Ն 0.999). The doubling time was calculated follows: doubling time ϭ [(t 2 Ϫ t 1 ) ϫ log 2 ]/(log OD 660 at t 2 Ϫ log OD 660 at t 1 ), where t 1 and t 2 are the times at the start and the end of the logarithmic growth phase. At least three independent experiments were carried out.
Autolysis assay. Triton X-100-stimulated autolysin activity in TrisHCl buffer (pH 7.5) was measured as described previously (28) . Cells were grown to mid-exponential phase to an OD 660 of about 1.5, with a cultivation temperature of 37°C. The culture was rapidly chilled, and cells were washed twice with ice-cold distilled water and suspended to an OD 660 of 1.5 in 50 mM Tris-HCl buffer supplemented with 0.05% Triton X-100. Autolysis was measured during incubation at 30°C as a decrease in the OD 660 by using a model TN-2612 biophotorecorder (Advantec Osaka, Japan). All data from the autolysis experiments are reported as percentages of the initial turbidity (at the zero time point) and are representative of three independent experiments.
RNA preparation and microarray analysis. RNA extraction, cDNA labeling, hybridization, and data analysis for microarray analysis were carried out according to protocols described previously (29) .
Western blot analysis. The strains were assayed for PBP2= production by Western blotting. S. aureus membrane proteins were prepared from mid-exponential-stage cultures. An overnight culture (0.1 ml each) was inoculated into 15 ml of fresh BHI broth and allowed to grow to an optical density at 660 nm of 1.0. Then each strain was induced by methicillin at 0, 1, 8, or 128 mg/liter for 1 h, as described previously (10) . The cells were harvested and washed with buffer (50 mM Tris, 150 mM NaCl, 5 mM MgCl 2 [pH 7.5]) and then resuspended in the same buffer. Lysostaphin, DNase, and RNase were added to final concentrations of 200, 20, and 10 mg/liter, respectively, and then the mixture was incubated at 37°C for 30 min. The lysed cells were centrifuged at 4,400 ϫ g for 10 min, and the supernatant was ultracentrifuged at 110,000 ϫ g for 40 min. The resultant pellet was washed twice and resuspended in 50 mM phosphate buffer (pH 7.0). Membrane proteins were separated by sodium dodecyl sulfate-poly-
FIG 2
Investigation of Eagle-type phenotype for methicillin in N315 rpoB(N967I) by Etest. The hetero-type strain (pre-MRSA) N315, homo-type strain ⌬IP-H5, and Eagle-type strain N315h4 were used as parent or control strains. The control strains N315, N315⌬IP, ⌬IP-H5, and ⌬IP-H14 and constructed mutant strain H5 rpoB(I967N) were inoculated with 10 8 CFU according to the manufacturer's recommendation. N315h4 and N315 rpoB(N967I) strains were inoculated with 10 11 CFU. The reason for the inoculation with 10 11 CFU was that the double inhibitory zone could be detected more clearly. There is no difference between MIC values with inoculum sizes of 10 11 CFU and 10 8 CFU. An Eagle-type MRSA strain grows better on agar plates containing high concentrations of methicillin than on those with low concentrations of methicillin. The single inhibitory zone was visible with the pre-MRSA N315 and hetero-type MRSA N315⌬IP strains but not, however, with the homo-type MRSA strains.
acrylamide gel electrophoresis and transferred as described previously (12) . PBP2= was detected with a mouse anti-PBP2= monoclonal antibody (a gift of Denka Seiken Co., Ltd., Niigata, Japan) as the primary antibody (diluted 1:100,000) and alkaline phosphatase-conjugated anti-mouse immunoglobulin (Promega, Madison, Wis.). We detected bound antibodies by a color development system (Bio-Rad), as directed by the manufacturer.
Statistical analysis of data. The statistical significance of the data was evaluated with Student's t test.
Microarray data accession number. The transcriptional profiles of ⌬IP-H5 relative to N315⌬IP and of N315 rpoB(N967I) relative to N315 are deposited in the NCBI under GEO accession number GSE42218.
RESULTS
A single amino acid substitution of rpoB(N967I) was detected in homo-MRSA strain ⌬IP-H5. To find the chr* genetic determinant, we determined the whole genomic sequence of homo-MRSA strain ⌬IP-H5 (oxacillin MIC of Ͼ256 mg/liter) which had been obtained from hetero-MRSA strain N315⌬IP (oxacillin MIC of 8 mg/liter) by selection with 8 mg/liter of imipenem (30) . We have already reported that the imipenem population analysis for N315⌬IP (imipenem MIC of 0.25 mg/liter) was performed, and a selective concentration of imipenem was defined as the concentration which resulted in a reduction of the initial bacterial population by approximately 4 log units (Fig. 1A) (20) . The imipenem MIC increased to Ͼ32 mg/liter from 0.25 mg/liter in ⌬IP-H5 (Table 2). Alignment of a 2,735,083-bp-long chromosome sequence of ⌬IP-H5 with that of the parent strain N315⌬IP revealed a single mutation in the rpoB gene with the amino acid change Asn967¡Ile (N967I). The amino acid substitution N967I was located outside the rifampin resistance-determining region (RRDR) (31) .
The rpoB(N967I) mutation changes phenotypic expression of ␤-lactam resistance. To verify the effect of rpoB(N967I), we constructed two mutant strains, N315 rpoB(N967I) and H5 rpoB(I967N), which were derived from pre-MRSA strain N315 and homo-MRSA strain ⌬IP-H5, respectively. H5 rpoB(I967N) was the reverse (or back) mutant of ⌬IP-H5 that has the rpoB(N967I) mutation. We then determined the antibiograms of these mutants together with their parent strains by Etest and population analysis. As shown in Table 2 , the MICs of methicillin (Fig.  2) , oxacillin, and imipenem in the back-mutant strain H5 rpoB(I967N) reverted to the level of parent strain N315⌬IP. Also, the pattern of the population analysis curve for methicillin in H5 rpoB(I967N) also returned to the heterogeneous type (Fig. 1B) .
On the other hand, N315 rpoB(N967I) exhibited Eagle-type resistance with a unique inhibitory zone on the agar plate containing lower concentrations of methicillin (from 2 to 12 mg/liter) and grew better on the agar plates containing high concentrations of methicillin (from 12 to Ͼ256 mg/liter) (Fig. 2) . The population analysis curve of N315 rpoB(N967I) showed an Eagle-type pattern similar to that of N315h4 (Fig. 1B) . Other MICs for vancomycin, rifampin, and daptomycin did not change among all the tested strains, except for a decreased linezolid MIC for the Eagle-type strain N315h4 (Table 2) . Eagle-type resistance occurs because of the poor induction of mecA gene expression by methicillin at lower concentrations (10) . In this regard, oxacillin seemed to be a much better inducer of mecA gene transcription, and Eagle-type resistance is not clearly demonstrated by population analysis using oxacillin (data not shown). This coincides with the MIC data in Table 2 : the double inhibitory zone was observed with methicillin and imipenem in the two Eagle-type strains but not with oxacillin (Ͼ256 mg/liter) (Fig. 2) . rpoB(N967I) confers high-dose methicillin tolerance in N315. Eagle-type strain N315h4 is known to exhibit tolerance to the killing activity of high concentrations of methicillin (10) . As shown in Fig. 3 , N315h4 demonstrated equivalent susceptibility to N315 to 8 mg/liter of methicillin. However, N315h4 exhibited reduced susceptibility to the cytokilling activity of methicillin at 128 mg/liter. This high-dose methicillin tolerance was also observed with N315 rpoB(N967I) (Fig. 3) . Homo-MRSA strain ⌬IP-H5 is resistant to high concentrations of methicillin, so it increases in cell number in the presence of 128 mg/liter of methicillin. On the other hand, ⌬IP-H5 rpoB(I967N) harboring the reverted wild-type rpoB gene lost both resistance and tolerance to methicillin and returned to the pattern of the cytokilling profile of N315⌬IP (Fig. 3) . Thus, the mutation rpoB(N967I) was shown to confer on the cells tolerance to high doses of methicillin.
PBP2= production in the rpoB mutant strains in response to methicillin. To verify the amount of PBP2= in all of the tested strains, we performed Western blot analysis for PBP2=. The amount of PBP2= was measured before and after exposure to 1, 8, or 128 mg/liter of methicillin for 1 h (Fig. 4) . We have already reported that N315 produced a very low-level amount of PBP2= before induction with methicillin because of the mecI gene-mediated repression of mecA gene transcription (12) . In contrast, N315⌬IP was found to produce detectable amounts of PBP2= without methicillin induction because PBP2= production was derepressed by the absence of mecI gene (Fig. 4) . PBP2= was produced constitutively in homo-MRSA ⌬IP-H5 and hetero-MRSA H5 rpoB(I967N) in the absence of the mecI repressor gene of mecA, both before and after induction with methicillin (Fig. 4) .
The PBP2= production in the two Eagle-type MRSA strains N315h4 and N315 rpoB(N967I) was also repressed both before and after induction with 0 and 1 mg/liter of methicillin, as described previously (10) . Induction with 8 and 128 mg/liter of methicillin was able to induce PBP2= production appreciably.
Eagle-type strain N315h4 carries the rpoB(R644H) mutation. To investigate the genetic alteration responsible for the Eagle-type resistance of N315h4, we determined its whole genome sequence and compared it with that of N315. We found only one mutation in rpoB in the N315h4 chromosome, and no other mutation was found. However, the amino acid position and substitution were different from those of ⌬IP-H5, which carried R644H. Thus, certain rpoB mutations are capable of conferring high-dose methicillin tolerance and homo-as well as Eagle-type methicillin resistance.
Both rpoB(N967I) and rpoB(R644H) mutations prolong the doubling time and bring about thickening of the cell wall. All three rpoB mutant strains, N315 rpoB(N967I), N315h4, and ⌬IP-H5, had prolonged doubling times compared with their parent strain N315 or with N315⌬IP carrying the wild-type rpoB gene (Table 2) . Electron microscopic observation revealed that ⌬IP-H5 had a thicker cell wall (21.6 Ϯ 1.8 nm) than N315⌬IP (17.7 Ϯ 1.5 nm) and its back-mutant strain H5 rpoB(I967N) (14.2 Ϯ 1.2 nm). The cell wall of Eagle-type strains N315h4 (20.2 Ϯ 1.8 nm) and N315 rpoB(N967I) (17.2 Ϯ 1.8 nm) were thicker than the cell wall of the parent strain N315 (14.1 Ϯ 1.3 nm). The significant difference between the rpoB mutant strains and wild-type rpoB strains was determined by a two-sided Student's t test (P Ͻ 0.018). The results indicated that the doubling time prolongation and cell wall thickening were associated with the rpoB(N967I) mutation.
Transcriptional profiles were changed by the rpoB(N967I) mutation. Microarray analysis of ⌬IP-H5 and N315 rpoB(N967I) revealed 147 and 163 differentially expressed genes, respectively, compared to the parent strains. Among the genes, 33 downregulated and 38 upregulated genes, respectively, were commonly found in ⌬IP-H5 (compared to N315⌬IP) and N315 rpoB(N967I) (compared to N315), except for sa2430 encoding the zinc metalloproteinase aureolysin (Table 3) . With reference to the tolerance phenotype of the rpoB(N967I) mutation, we noticed a change in expression of the genes involved in autolysin activity and the cell wall synthesis function. The transcriptional level of cidABC encoding the complex up-regulatory system for autolysin activity (32) (33) (34) (35) (36) was decreased by 0.42-, 0.48-, and 0.44-fold in ⌬IP-H5 relative to N315⌬IP and by 0.25-, 0.27-, 0.26-fold in N315 rpoB(N967I) relative to N315, respectively. On the other hand, the expression levels of the negative regulators of autolysis, lrgAB (35, 37) , were increased by 2.53-and 2.08-fold in ⌬IP-H5 relative to N315⌬IP and by 6.60-and 6.57-fold in N315 rpoB(N967I) relative to N315, respectively.
The effect of rpoB(N967I) on Triton X-100-stimulated autolytic activity. To observe the effect of rpoB(N967I) on the regulation of the genes involved in autolysis, we tested Triton X-100-induced autolysis of the rpoB(N967I) mutant strains (Fig. 5) . The two rpoB(N967I) mutants, N315 rpoB(N967I) and ⌬IP-H5, had significantly decreased Triton X-100-induced autolysis rates (50% lysis in about 100 to 110 min) compared to their parent strains N315 and N315⌬IP (50% lysis in 40 to 60 min). Moreover, N315h4 carrying rpoB(R644H) also exhibited a decrease in autolysis compared to the parent strain N315. These results indicated that the rpoB(N967I) and rpoB(R644H) mutations were correlated with the level of autolytic activity in S. aureus.
DISCUSSION
This study demonstrated that two mutations in the RNA polymerase ␤ subunit, rpoB(N967I) and rpoB(R644H), cause heterogenous-to-homogeneous and heterogeneous-to-Eagle-type phenotypic conversion of methicillin resistance. These rpoB mutations would constitute an important category of chr* mutations (6). RpoB has been well known as the target of rifampin. The mutation of rpoB has been assigned significance only as the resistance marker for rifampin. However, we noticed a variety of rpoB mutations that affected various important antibiotics other than rifampin. In addition to rifampin resistance, rpoB(H481Y) raises vancomycin resistance and promotes the heterogeneous vancomycin-intermediate S. aureus (hVISA)-to-VISA conversion (20, 22) . rpoB(Q468K) raises resistance to both rifampin and daptomycin (22) . The rpoB mutations such as rpoB(T480M) and rpoB(R503H) do not affect rifampin susceptibility (MICs of 0.016 and 0.031, respectively), whereas they are associated with the raised resistance to teicoplanin, vancomycin, and daptomycin (22) .
The rpoB mutations causing either VISA or daptomycin resistance are commonly associated with such phenotypes as prolonged doubling time and increased linezolid susceptibility (23, 24, 38) . As shown here, the two rpoB mutations promoting the conversion of heterogenous to homogeneous methicillin resistance also share the same features of prolonged doubling time and increased linezolid susceptibility. Introduction of an rpoB(H481Y) mutation causes thickening of the cell wall, which is the cardinal feature of the VISA phenotype (22) . rpoB(N967I) also had this effect. It seems that cell wall thickening is a common feature of rpoB mutation. However, the cell wall thickening by rpoB(N967I) did not accompany an increase in vancomycin resistance, as was the case with the rpoB(H481Y) mutation (20, 22) .
Interestingly, microarray results of ⌬IP-H5 relative to those with N315⌬IP showed that the transcriptional level of cidABC encoding a complex upregulatory system for autolysin activity was decreased. In contrast, the expression level of the negative regulator of autolysis, lrgAB, was increased. Furthermore, the autolytic activity was decreased in the rpoB(N967I) mutants shown in Fig.  4 . The S. aureus cidABC operon is reported to encode a complex regulatory system that affects murein hydrolase activity, antibiotic tolerance, and cell viability in stationary phase (32) (33) (34) (35) (39) (40) (41) . Disruption of the cid operon causes decreased murein hydrolase activity and increased tolerance to antibiotics, whereas an lrg mutation causes increased murein hydrolase activity and decreased antibiotic tolerance (33) (34) (35) . It is suggested that rpoB mutations decrease autolysis by modulating the expression of lrg and cid operons.
In N315 with its mecA gene expression strongly repressed by MecI, cells are killed by the presence of high concentrations of methicillin (Fig. 3) . However, as illustrated in Fig. 6 , rpoB(N967I) and rpoB(R644H) mutations allow the cell to tolerate the presence of methicillin and receive the benefit of PBP2=, which is induced only by high concentrations of methicillin (Fig. 4 and Fig. 5 ). The mutations make N315 express Eagle-type resistance. When the same mutations occur in N315⌬IP, in which the mecA gene is constitutively transcribed, homogeneous methicillin resistance is expressed as with strain ⌬IP-H5 (Fig. 4 and Fig. 5) .
rpoB mutations are responsible for the progression of vancomycin resistance from hetero-VISA to VISA (21, 22) . Here, we showed that two rpoB mutations cause heterogeneous-to-homogeneous conversion of methicillin resistance. We consider that the rpoB mutation is a major cause of the phenotype of high resistance to both methicillin and vancomycin. The locations of the mutations in the rpoB gene and the kinds of amino acid substitutions would confer on the cell not only resistance to various combinations of antibiotics but also various degrees of resistance (Fig. 6) . The characteristic shape of the population curve of hetero-MRSA strains would thus be explained by the presence of cells with various rpoB mutations.
In addition to vancomycin, rifampin also can select VISA out of hetero-VISA strains (21, 22) . This illustrates that some rpoB mutations confer cross-resistance to both vancomycin and rifampin. To test if this is also the case for ␤-lactam and rifampin, we obtained 50 rpoB mutants by selecting hetero-MRSA strain N315⌬IP with rifampin. We found three of these mutants were converted to homo-MRSA (Yuki Katayama, unpublished data). Thus, the rpoB gene seems to be a key target of mutations that modulate the resistance phenotype to various antibiotics. Exhaustive listing of rpoB gene mutations and their roles in antibiotic resistance expression would be worthwhile.
